Physician profile
Angela Azar
NPI 1003988718
$12,423.35
in general payments reported to CMS, 2019-2025
38 companies · $2,245 in 2025
The $2,245 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2020: $1,239 · 2021: $1,880 · 2022: $1,458 · 2023: $1,809 · 2024: $2,355 · 2025: $2,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,266 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,266.10 |
| Education | $142.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $1,054.34 | 2023-2025 | Zoryve |
| Abbvie INC. | $928.96 | 2019-2025 | Skyrizi, Rinvoq |
| Pfizer INC. | $804.59 | 2019-2025 | |
| Amgen INC. | $796.37 | 2020-2025 | Otezla, Otezla |
| Lilly USA, LLC | $771.26 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $718.36 | 2019-2025 | |
| Incyte Corporation | $654.63 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $624.10 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $603.53 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $574.87 | 2019-2025 | Cabtreo, Duobrii, Arazlo |
| Leo Pharma INC. | $547.82 | 2019-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $462.77 | 2020-2025 | Dupixent |
| Genzyme Corporation | $424.37 | 2019-2025 | |
| Galderma Laboratories, L.P. | $389.30 | 2019-2025 | Nemluvio, Aklief, Twyneo |
| Smith+Nephew, INC. | $377.05 | 2019-2025 | Collagenase Santyl |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $345.28 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $283.16 | 2019-2023 | |
| Almirall LLC | $279.41 | 2020-2025 | Klisyri, Seysara |
| Sun Pharmaceutical Industries INC. | $224.73 | 2020-2025 | Winlevi |
| Organon LLC | $212.03 | 2025 | Vtama |
| Merz North America, INC. | $197.32 | 2021-2022 | |
| Botanix Sb INC | $184.72 | 2025 | Sofdra |
| E.R. Squibb & Sons, L.L.C. | $173.56 | 2022-2024 | Sotyktu |
| Encore Dermatology INC. | $139.81 | 2019 | |
| Biofrontera INC. | $95.29 | 2019-2021 | |
| Allergan, INC. | $74.72 | 2019-2021 | |
| Epi Health, LLC | $69.73 | 2021-2022 | |
| Dermira, INC. | $67.02 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $64.95 | 2022 | |
| Celgene Corporation | $57.38 | 2019 | |
| Cipher Pharmaceuticals US LLC | $45.25 | 2025 | Spinosad, Natroba |
| Stemline Therapeutics INC. | $38.44 | 2020 | |
| Journey Medical Corporation | $36.38 | 2021-2023 | |
| Sebela Pharmaceuticals INC. | $29.83 | 2022-2023 | Pramosone, Naftin |
| Ucb, INC. | $24.50 | 2024 | Bimzelx |
| Shield Therapeutics INC | $22.86 | 2025 | |
| Hologic Sales and Service, LLC | $14.66 | 2022 | |
| Glenmark Therapeutics INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.